Vanguard Group Inc. increased its holdings in Cannae Holdings, Inc. (NYSE:CNNE - Free Report) by 3.6% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,844,675 shares of the company's stock after purchasing an additional 205,785 shares during the period. Vanguard Group Inc. owned approximately 9.30% of Cannae worth $107,133,000 as of its most recent SEC filing.
A number of other institutional investors also recently made changes to their positions in CNNE. Saba Capital Management L.P. raised its holdings in Cannae by 92.3% during the 4th quarter. Saba Capital Management L.P. now owns 2,219,230 shares of the company's stock valued at $44,074,000 after buying an additional 1,065,083 shares during the last quarter. Carronade Capital Management LP grew its position in shares of Cannae by 145.5% in the 4th quarter. Carronade Capital Management LP now owns 1,728,926 shares of the company's stock worth $34,336,000 after buying an additional 1,024,663 shares during the period. Private Management Group Inc. grew its position in shares of Cannae by 91.1% in the 1st quarter. Private Management Group Inc. now owns 1,601,334 shares of the company's stock worth $29,352,000 after buying an additional 763,324 shares during the period. Invenomic Capital Management LP purchased a new stake in Cannae during the 4th quarter valued at about $10,174,000. Finally, Alberta Investment Management Corp purchased a new stake in Cannae during the 1st quarter valued at about $7,790,000. Hedge funds and other institutional investors own 88.12% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Royal Bank Of Canada raised their price target on shares of Cannae from $22.00 to $26.00 and gave the company an "outperform" rating in a report on Thursday, July 10th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average target price of $24.00.
Read Our Latest Analysis on CNNE
Cannae Trading Down 0.6%
Shares of CNNE traded down $0.12 during trading hours on Wednesday, reaching $18.64. 242,707 shares of the company traded hands, compared to its average volume of 654,786. The firm has a market cap of $1.04 billion, a price-to-earnings ratio of -2.78 and a beta of 1.06. Cannae Holdings, Inc. has a 12-month low of $15.91 and a 12-month high of $22.36. The company has a current ratio of 2.78, a quick ratio of 2.78 and a debt-to-equity ratio of 0.05. The stock's fifty day moving average price is $20.35 and its 200 day moving average price is $19.00.
Cannae Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a dividend of $0.15 per share. This is an increase from Cannae's previous quarterly dividend of $0.12. This represents a $0.60 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend is Tuesday, September 16th. Cannae's payout ratio is presently -7.16%.
Cannae Profile
(
Free Report)
Cannae Holdings, Inc is a principal investment firm. The firm primarily invests in restaurants, technology enabled healthcare services, financial services and more. It takes both minority and majority stakes. Cannae Holdings, Inc was founded in 2014 and is based in Las Vegas, Nevada.
Further Reading

Before you consider Cannae, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cannae wasn't on the list.
While Cannae currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.